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Abstract
Objectives: The objective of our study was to investigate the relationship between catastrophic health expenditure
(CHE) and health-related quality of life (HRQoL) in general population.
Methods: We used Korean Health Panel Survey data from 2011 to 2013, which included data from 8850 baseline
participants of 19 years of age or older. We defined CHE as total annual out-of-pocket health payment that was
40% greater than the household’s capacity to pay. HRQoL was measured using the EuroQol-visual analogue scale
(EQ-VAS). We used generalized estimating equations to perform a longitudinal regression analysis.
Results: A total of 4.5% of the participants (n = 398) experienced CHE. Those with CHE tended to have a lower
EQ-VAS index score compared with those without CHE (β: − 1.34, p = 0.013). A subgroup analysis revealed that
individuals experiencing CHE had significant decreases as the number of chronic diseases increased (three or more,
β: − 1.85, p = 0.014).
Conclusions: Catastrophic health expenditure influences HRQoL, which was more pronounced in patient with chronic
disease. The efforts should focus on people who suffer from excessive health expenditures and chronic diseases.
Keywords: Catastrophic health expenditure, Health-related quality of life, Out-of-pocket health payment,
Chronic disease
Introduction
Health-related quality of life (HRQoL) is a multi-dimen-
sional concept that includes domains related to physical,
mental, emotional, and social functioning and the social
context in which people live [1]. HRQoL is an important
outcome used in a variety of medical research disci-
plines to ascertain aspects of well-being in settings of
health and disease. Since 1949, the World Health
Organization (WHO) has emphasized the importance
of HRQoL [2]. The WHO’s ‘Healthy People 2020’ ini-
tiative emphasizes HRQoL as one of its four over-
arching goals [3].
As factors affecting HRQoL vary, HRQoL has been an-
alyzed as an outcome in a variety of populations and set-
tings [4]. Previous studies to clarify the factors affecting
HRQoL have generally considered physical functioning
(e.g., overall physical health, physical functioning, pain,
fatigue), disease-specific (e.g., cancer, chronic disease),
health care service use (e.g., unmet healthcare needs)
factors as relevant [5–9]. In particular, not only burden
for clinical status but also socio-economic burden can
also affect HRQoL. For example, financial hardship was
associated with degenerated physical and psychological
heath, thereby exacerbating HRQoL [10]. In addition,
financial hardship that occurs after receiving
hematopoietic cell transplantation was associated with
worse quality of life and exacerbated perceived stress
[11]. Studies on this topic have focused primarily on spe-
cific disease with high medical expenditures such as can-
cer. On the other hands, in line with the increasing
trend of socio-economic burden of chronic disease such
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as non-communicable disease [12], study reported that
high medical expenditure including out-of-pocket ex-
penditure in type 2 diabetic patients was associated to
poor health-related quality of life [13]. Especially, house-
hold members with chronic illness are the major factors
affecting financial catastrophe, financial hardship of
healthcare was greater for subjects affected by chronic
disease than those unaffected [14–16]. Hence, cata-
strophic healthcare expenditure which implies a financial
hardship due to medical expenditure may impact on
health-related quality of life. Only a few studies have ad-
dressed this issue. This topic is especially relevant to
countries with concerns about health-related life satis-
faction and health service utilization.
In Korea, subjective health satisfaction is the lowest
among all OECD countries. According to an OECD re-
port, only 35.1% of Koreans ≥15 years of age believe their
health condition to be “good”. This value is approximately
one-half the OECD average of 69.2%. Hence, it is neces-
sary to examine health-related life satisfaction issues in
terms of promotion and identification of the factors that
affect HRQoL. In addition, a national health insurance
system provides universal healthcare coverage in Korea,
but there are barriers to medical care access because high
out-of-pocket payments (OOP) cause catastrophic health
expenditures (CHEs). Overall, the South Korean OOP
payment for healthcare is the highest among OECD coun-
tries (Korea: 4.7%; OECD average: 2.8%) [17]. Korea also
has a relatively greater proportion of households with
catastrophic expenditures [17, 18].
Therefore, the present study used longitudinal data
and analysed the effects of catastrophic health expend-
iture on HRQoL in the general population. In addition,
we examined the relationship between CHE and HRQoL
by number of chronic disease.
Materials and methods
Study population
We used raw data from the Korean Health Panel
Study (KHPS) conducted in 2008 and 2013. The
group of study participants was a nationally represen-
tative sample of Korean. The KHPS is a panel survey
conducted annually by the Korean Institute for Health
and social Affairs in conjunction with the National
Health Insurance service on a nationally representa-
tive sample of South Korean household. Households
are selected using a stratified multistage probability
sampling design in order to select nationwide sub-
jects. The KHPS comprised three parts—household,
individual, and case-based sections—all of which were
performed by trained medical staff through a com-
puter assisted personal interviewing. The household
survey included questions about general characteris-
tics, living expenses, pharmaceutical product
purchases, and private health insurance with associ-
ated premiums. The individual survey considered the
demographic characteristics of the subjects. The
case-based survey was designed only for individuals with
chronic diseases and those receiving inpatient treatment,
outpatient treatment, or emergency-service utilization. We
used data from all three surveys. Detail of the datasets are
available at https://www.khp.re.kr:444/eng/main.do.
The KHPS began in 2008, but the monthly food ex-
pense variable used to calculate CHE was recorded be-
ginning in 2011. Thus, we used data from the KHPS
between 2011 and 2013. In addition, KHPS was released
to raw data until 2015, but EQ-VAS was not measured
in 2014 and 2015, so it was not used in the analysis. Our
sample was restricted to individuals aged 19 years or
older. To analysis only newly onset catastrophic health
expenditure, we excluded respondents who responded
that they experienced catastrophic health expenditure in
2011. Of the 12,683 in 2011, subjects with catastrophic
health expenditure and without follow-up in 2012 were
not included in the analysis; 1838 participants were ex-
cluded. Then 10,845 subjects were followed up in 2012.
Of the 10,845 subjects in 2012, after excluding subjects
with any missing values or without follow-up in 2013, a
total of 8850 subjects remained in this study. Thus,
baseline included 8850 subjects with a 2-year follow-up
(see details in Fig. 1).
We used public KHPS data, which did not include any
information that could be used to identify individuals.
The survey’s design and methods conformed to local
regulations and Declaration of Helsinki standards. The
data, and the permission to use and analyze the data,
were provided by KIHASA.
Measures
Health-related quality of life
We measured HRQoL using the EuroQoL-visual
analogue scale (EQ-VAS) index. EQ-VAS is a self-rated
health questionnaire presented as a vertical visual
“thermometer” with end-point values of 100 (best im-
aginable HRQoL) and 0 (worst imaginable HRQoL).
Higher scores correspond to a higher HRQoL.
Catastrophic health expenditure
We used the WHO standard threshold to define CHE as
a total annual OOP health payment that is 40% greater
than the household’s capacity to pay [19].
The capacity to pay is defined as the economic power
to which a household can purchase a particular goods or
service, except for expenditure necessary for a living. We
used Xu et al.’s measure to define the capacity to pay as
the amount of money available after excluding food ex-
penses [20]. The monthly food expenditure was
deducted from the monthly living expenditure, and then
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multiplied by 12 to obtain the yearly payment
conversion.
The OOP was defined as medical expenses borne by
the family at the time of receiving the health care ser-
vices as defined by the WHO [19]. The annual OOP
health payment was calculated by including medical and
drug costs resulting from emergency, outpatient care,
and hospitalization, services. Indirect medical costs (e.g.,
including transportation or nursing costs) were excluded
from the calculation.
CHE ¼ household out−of−pocket health expenditure
household expenditure excluding food expensesð Þ > 40%
Covariates
We included several demographic, socioeconomic,
and health-related variables as covariates. The demo-
graphic variables included sex and age. The socioeco-
nomic variables included education level (elementary
school or below, middle school or high school, col-
lege or above), economic activity (employed, un-
employed), family constitution (living alone, couple,
couple with child, more), health insurance type
(health insurance, medical aid), and income (low,
low-middle, middle, middle-high, high). The
health-related variables were the number of chronic
diseases, disability (yes, no), how perceive health
status (good, bad), depressive mood during the past
2 weeks (present, absent). Survey year was included
as a covariate.
Statistical analysis
Descriptive statistics were presented as number of sub-
jects and proportions. Univariate analyses were per-
formed to compare the mean EQ-VAS score values for
two groups using T-test as well as analysis of variance
(ANOVA) were performed to compare the mean
EQ-VAS score values among the three or more groups.
We evaluated the relationship between catastrophic
health expenditure and HRQoL using a generalized esti-
mating equation (GEE) model that was an extension of
the quasi-likelihood approach used to analyses longitu-
dinal correlated data [21]. The GEE model was used for
analyzing longitudinal data, as it accounted for time
variation and correlations between repeated measure-
ments. In details, the statistical analyses were performed
using the GENMOD procedure. It computes robust
standard error estimates by default and accounts for the
correlations among repeated measurements [22]. All in-
dependent variables were adjusted. Finally, a subgroup
analysis was performed to evaluate a possible association
between catastrophic health expenditure and HRQoL
stratified by number of chronic disease.
Fig. 1 Flow chart of participant selection process
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The analyses were performed using SAS 9.4 (SAS
Institute, Cary, North Carolina, USA) and p-values were
two-sided and considered significant at p < .05.
Results
In our study, 8850 subjects were included to assess the
association between catastrophic health expenditure
and health-related quality of life. Table 1 shows the
baseline characteristics of the study population.
Among the 8850 subjects, 4.5% (n = 398) experienced
catastrophic health expenditure. The mean baseline
EQ-VAS score was 70.76 ± 15.39. The EQ-VAS score
value was lower for those who experienced CHE
(64.46 ± 17.56) compared with those who did not ex-
perience CHE (71.06 ± 15.21). Lower scores indicated
more severe status in HRQoL.
Table 2 shows the association between CHE experien-
cing and HRQoL while adjusting for all independent var-
iables. Those with CHE experiencing tended to have
lower EQ-VAS index values compared with those with-
out CHE (β: − 1.34, p = 0.013). A more detailed examin-
ation of the relationship between experiencing CHE and
HRQoL revealed that respondents ≥70 years of age
tended to have lower EQ-VAS index values compared
with respondents 19~29 years of age (β: − 1.72,
p = 0.010). An examination based on income revealed
that EQ-VAS values increased as income increased (i.e.,
low < middle-low < middle < middle-high < high; low: −
3.26, middle-low: − 1.69, middle: − 1.75, middle-high: −
0.94). Respondents with ≥3 chronic diseases had lower
EQ-VAS scores compared with those without any
chronic diseases (β: − 3.11, p < 0.001).
The subgroup analysis results are shown in Table 3.
Subjects with CHE and greater chronic disease (3 or
more) exhibited a drastic decrease in HRQoL.
Discussion
We found that after adjustment for multiple variables,
CHE was significantly associated with degenerated
HRQoL in the general population. The results of our
subgroup analysis indicated that the association be-
tween CHE and HRQoL was stronger in individuals
with chronic disease.
These findings can be explained by the associations
between financial burden and life satisfaction. Previ-
ous studies have examined the associations between
economic hardship and life satisfaction and have
found that financial burden has adverse consequences
on life satisfaction characteristics [23–25]. Studies of
catastrophic expenditure revealed that there is a ro-
bust association between excessive expenditure for
healthcare and financial strain (e.g., onset of poverty).
Hence, experiencing CHE may increase financial
strain and result in a deteriorating HRQoL.
Consistent with previous studies on financial hardship,
cancer survivors in the USA who have financial burdens
(e.g., borrowed money) are more likely to have low Phys-
ical Component and Mental Component scores and are
therefore more likely to experience a depressed mood
[26]. Patients in the UK who have head and neck cancer
that has resulted in serious effects on household finances
have poor HRQoL [27].
Populations who suffer from a chronic disease are
more likely to experience CHE because medical ex-
penditures are likely to continue for a long period.
As expenditures for chronic disease treatment accu-
mulate, individuals or households are more likely to
compromise healthy lifestyle choices. For example,
they cannot afford fresh fruits and vegetables, which
are more expensive than processed foods [28]. There-
fore, chronic disease has the potential to negatively
affect health-related life satisfaction characteristics
[29]. This phenomenon has been found in developing
[30] countries and in the wealthiest countries in
Europe [31].
Our study revealed that 4.5% of households in
Korea experienced CHE. This estimate is similar to
the 3.0% that the OECD reported for 2012 using
Korea national statistics. This value is also the high-
est among OECD countries [32]. Among developed
countries, only Portugal, Greece, Switzerland, and the
United States have 0.5% or more of households with
catastrophic-level health spending. OOP payments for
healthcare can cause households to incur cata-
strophic expenditures [33, 34]. Therefore, this result
for Korea is expected because OOP spending as a
share of total health expenditure is relatively high
(Korea = 36%; OECD average = 19%) [35]. High OOP
payments may create barriers to medical utilization
that cause delays in care, low screening rates among
vulnerable people, and exacerbate inequities in health
status and in health-related life satisfaction
characteristics.
Even when we excluded households that experi-
enced CHE in the most recent year, the mean
EQ-VAS score at baseline was 70.8; this value was
less than that of the general population of China
(80.1) [36] and of the mean overall score of six
European countries (77.1) [37]. South Korea currently
has serious life satisfaction issues. Koreans are sub-
stantially less satisfied with their lives compared with
residents of OECD countries. The ‘Better Life Index’
report presents results for eleven parameters (e.g., in-
come, jobs, health and work-life balance); Korea
ranked 29th among OECD countries in 2014 (Korea’s
score: 5.8/10; OECD average: 6.6/10). The results for
the self-reported health measure of health-related life
satisfaction indicated that individual South Korean
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citizens have the least confidence in their own health
condition level. Taken together, these findings indi-
cate that effective strategies to manage HRQoL
among households with CHE should be designed and
implemented.
Our findings suggested that programs (e.g., medical
expense assistance) that support populations who ex-
perience CHE are needed to improving the quality of
life. The Korean government recently implemented the
pilot catastrophic healthcare expenditure aid program.
This public assistance program targets poor individuals
who experience catastrophic healthcare expenditure due
to major severe diseases (e.g., cancer, cardiovascular dis-
ease, rare diseases).
We suggest that countries with low financial assistance
levels for healthcare should aim to reduce the barriers
within the healthcare system and allocate resources to
strengthen healthcare coverage and increase healthcare
equity. These efforts should emphasize guarantee of
healthcare services for people who suffer from excessive
health expenditures and chronic disease.
This study had some limitations. First, the EQ-VAS
measures current health status and CHE was measured
using yearly health expenditure data. Therefore, the
effects from external events might have moderated or
reinforced the HRQoL results. Second, we used the
EQ-VAS to measure HRQoL, which depends on the par-
ticipant’s subjective perception. However, the EQ-VAS is
widely used for HRQoL studies. Third, due to limitations
of our data, we measured short-term effects (i.e., 2 years).
Further studies of longer-term effects of CHE are
needed.
Despite the limitations, this study is the first to in-
vestigate associations between CHE and HRQoL
Table 1 General characteristics of study population at baseline
in 2012
Variables EQ-VAS
N (%) Mean ± S.D t / F value p-value
Catastrophic expenditure −7.37 <.0001
Yes 398 (4.5) 64.46 ± 17.56
No 8452 (95.5) 71.06 ± 15.21
Sex 8.42 <.0001
Male 3834 (43.3) 72.32 ± 14.72
Female 5016 (56.7) 69.57 ± 15.78
Age 104.34 <.0001
19~ 29 733 (8.3) 75.19 ± 14.60
30~ 39 1421 (16.1) 73.56 ± 14.55
40~ 49 2057 (23.2) 73.65 ± 13.37
50~ 59 1693 (19.1) 70.86 ± 14.55
60~ 69 1503 (17.0) 68.36 ± 16.03
70+ 1443 (16.3) 64.03 ± 16.88
Education level 281.25 <.0001
Elementary or
below
1912 (21.6) 64.16 ± 16.87
Middle/high
school
3955 (44.7) 71.14 ± 14.85
College or above 2983 (33.7) 74.49 ± 13.63
Economic status 10.29 <.0001
Employed 5498 (62.1) 72.11 ± 14.46
Unemployed 3352 (37.9) 68.55 ± 16.56
Income 117.73 <.0001
Low 1243 (14.0) 63.41 ± 17.67
Middle-low 1687 (19.1) 69.08 ± 15.39
Middle 1866 (21.1) 71.25 ± 14.82
Middle-high 1987 (22.4) 72.56 ± 14.56
High 2067 (23.4) 74.38 ± 13.41
Health insurance type 12.17 <.0001
Health insurance 8448 (95.5) 71.30 ± 14.96
Medical aid 402 (4.5) 59.39 ± 19.34
Family constitution 79.65 <.0001
Living alone 667 (7.5) 66.46 ± 17.12
Couple 1792 (20.3) 68.06 ± 16.37
Couple with
children
4803 (54.3) 73.00 ± 14.11
More 1588 (17.9) 68.87 ± 16.06
Number of chronic disease 225.56 <.0001
0 3180 (35.9) 74.92 ± 13.73
1 1794 (20.3) 72.41 ± 14.19
2 1252 (14.1) 70.00 ± 15.11
3+ 2624 (29.7) 64.96 ± 16.34
Table 1 General characteristics of study population at baseline
in 2012 (Continued)
Variables EQ-VAS
N (%) Mean ± S.D t / F value p-value
Disability 12.77 <.0001
Absent 8266 (93.4) 71.38 ± 15.04
Present 584 (6.6) 61.95 ± 17.40
Perceive health status 40.78 <.0001
Good 7478 (84.5) 73.72 ± 13.20
Bad 1372 (15.5) 54.62 ± 16.41
Depression mood −18.53 <.0001
Present 632 (7.4) 58.11 ± 18.03
Absent 8218 (92.9) 71.74 ± 14.72
Year
2012 8850 100.0 70.76 ± 15.39
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among the general Korean population. Given the high
values for incidence of catastrophic healthcare
expenditure and the low health-related satisfaction
levels in Korea, our findings are important for health
policy makers to identify solutions aimed at control
of HRQoL characteristics.
Conclusion
In conclusion, the present study found that catastrophic
health expenditure was to have an effect on HRQoL.
The HRQoL of participants with chronic disease was
significantly worse than that of other groups. The efforts
should focus on people who suffer from excessive health
expenditures and chronic diseases.
Table 2 Results of the GEE analyzing for the effect of
catastrophic health expenditure on EQ-VAS
Variables EQ-VAS
β S.E p-value
Catastrophic health expenditure
Yes −1.34 0.54 0.013
No Ref.
Sex
Male Ref.
Female −0.99 0.25 0.000
Age
19~ 29 Ref.
30~ 39 − 0.46 0.53 0.384
40~ 49 0.44 0.51 0.387
50~ 59 −0.26 0.56 0.642
60~ 69 −0.45 0.61 0.459
70+ −1.72 0.67 0.010
Education level
Elementary or below −2.40 0.45 <.001
Middle/high school −0.75 0.29 0.010
College or above Ref.
Economic status
Employed Ref.
Unemployed 0.44 0.26 0.099
Income
Low −3.26 0.48 <.001
Middle-low −1.69 0.36 <.001
Middle −1.75 0.34 <.001
Middle-high −0.94 0.31 0.002
High Ref.
Health insurance type
Health insurance Ref.
Medical aid −2.03 0.67 0.002
Family constitution
Living alone 0.91 0.51 0.073
Couple Ref.
Couple with children −1.19 0.36 0.001
More −1.80 0.40 <.001
Number of chronic disease
0 Ref.
1 −1.16 0.32 <.001
2 −1.82 0.38 <.001
3+ −3.11 0.36 <.001
Disability
Absent Ref.
Present −1.96 0.52 <.001
Table 2 Results of the GEE analyzing for the effect of
catastrophic health expenditure on EQ-VAS (Continued)
Variables EQ-VAS
β S.E p-value
Perceive health status
Good Ref.
Bad −14.90 0.37 <.001
Depression mood
Present −7.07 0.46 <.001
Absent Ref.
Year
2012 Ref.
2013 −0.83 0.18 <.001
Table 3 Results of the GEE analyzing for the effect of
catastrophic health expenditure on EQ-VAS by number of
chronic disease
Variables EQ-VAS
β S.E p-value
Number of chronic disease Catastrophic expenditure
0 No Ref.
Yes 0.53 1.35 0.696
Number of chronic disease Catastrophic expenditure
1 No Ref.
Yes −0.54 1.50 0.719
Number of chronic disease Catastrophic expenditure
2 No Ref.
Yes −2.17 1.23 0.077
Number of chronic disease Catastrophic expenditure
3+ No Ref.
Yes −1.85 0.75 0.014
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